← Back to catalogue

Pointe Calcium Arsenazo for BS480

FDA UDI

Class II (US FDA UDI)

by Pointe Scientific, Inc.

Identity

Trade Name
Pointe Calcium Arsenazo for BS480 FDA UDI
Generic Name
Calcium (Ca2+) IVD, kit, spectrophotometry FDA UDI
Device Name
Pointe Calcium Arsenazo packaged for the BS480 analyzer. 6x60mL Kit. For the quantitative determination of Calcium in serum or heparinized plasma. For in vitro diagnostic use only. FDA UDI
Model / Reference
14-C7529-360 FDA UDI
Description
Pointe Calcium Arsenazo packaged for the BS480 analyzer. 6x60mL Kit. For the quantitative determination of Calcium in serum or heparinized plasma. For in vitro diagnostic use only. FDA UDI

Identifiers

Catalog Number
14-C7529-360 FDA UDI
Primary DI / UDI-DI
00811727015754 FDA UDI
510(k) Number
K921625 FDA UDI
FDA Product Code
CIC FDA UDI
GMDN Term
Calcium (Ca2+) IVD, kit, spectrophotometry FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.1145 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Calcium (Ca2+) IVD, kit, spectrophotometry

Pointe Calcium Arsenazo for BS480 by Pointe Scientific, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Calcium (Ca2+) IVD, kit, spectrophotometry.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 897ad798-5794-424a-a6c8-265a45691340 37 fields · synced Jun 8, 2026